Logo image of ALNLF.PA

NEOLIFE (ALNLF.PA) Stock Fundamental Analysis

EPA:ALNLF - Euronext Paris - Matif - FR0011636083 - Common Stock - Currency: EUR

0.076  +0.01 (+13.77%)

Fundamental Rating

2

Overall ALNLF gets a fundamental rating of 2 out of 10. We evaluated ALNLF against 29 industry peers in the Professional Services industry. The financial health of ALNLF is average, but there are quite some concerns on its profitability. ALNLF does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ALNLF had negative earnings in the past year.
ALNLF had negative earnings in each of the past 5 years.
ALNLF had negative operating cash flow in 4 of the past 5 years.
ALNLF.PA Yearly Net Income VS EBIT VS OCF VS FCFALNLF.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -1M -2M -3M

1.2 Ratios

Looking at the Return On Assets, with a value of -1.77%, ALNLF is doing worse than 79.31% of the companies in the same industry.
The Return On Equity of ALNLF (-3.39%) is worse than 79.31% of its industry peers.
Industry RankSector Rank
ROA -1.77%
ROE -3.39%
ROIC N/A
ROA(3y)-18.07%
ROA(5y)-15.86%
ROE(3y)-31.58%
ROE(5y)-31.32%
ROIC(3y)N/A
ROIC(5y)N/A
ALNLF.PA Yearly ROA, ROE, ROICALNLF.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -50 -100 -150 -200 -250

1.3 Margins

Looking at the Gross Margin, with a value of 16.86%, ALNLF is doing worse than 72.41% of the companies in the same industry.
ALNLF's Gross Margin has declined in the last couple of years.
ALNLF does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-24.38%
GM growth 5YN/A
ALNLF.PA Yearly Profit, Operating, Gross MarginsALNLF.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60

More info and screens

4

2. Health

2.1 Basic Checks

ALNLF does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALNLF remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ALNLF has more shares outstanding
ALNLF has a better debt/assets ratio than last year.
ALNLF.PA Yearly Shares OutstandingALNLF.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
ALNLF.PA Yearly Total Debt VS Total AssetsALNLF.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M

2.2 Solvency

ALNLF has an Altman-Z score of 2.52. This is not the best score and indicates that ALNLF is in the grey zone with still only limited risk for bankruptcy at the moment.
ALNLF has a Altman-Z score (2.52) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.25 indicates that ALNLF is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.25, ALNLF belongs to the best of the industry, outperforming 82.76% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z 2.52
ROIC/WACCN/A
WACC6.88%
ALNLF.PA Yearly LT Debt VS Equity VS FCFALNLF.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M

2.3 Liquidity

ALNLF has a Current Ratio of 1.32. This is a normal value and indicates that ALNLF is financially healthy and should not expect problems in meeting its short term obligations.
ALNLF has a better Current ratio (1.32) than 72.41% of its industry peers.
A Quick Ratio of 0.86 indicates that ALNLF may have some problems paying its short term obligations.
ALNLF has a Quick ratio (0.86) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.86
ALNLF.PA Yearly Current Assets VS Current LiabilitesALNLF.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 96.39% over the past year.
ALNLF shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -45.22%.
Measured over the past years, ALNLF shows a quite strong growth in Revenue. The Revenue has been growing by 14.19% on average per year.
EPS 1Y (TTM)96.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)-45.22%
Revenue growth 3Y17.93%
Revenue growth 5Y14.19%
Sales Q2Q%-18.81%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALNLF.PA Yearly Revenue VS EstimatesALNLF.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
ALNLF.PA Yearly EPS VS EstimatesALNLF.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
ALNLF.PA Price Earnings VS Forward Price EarningsALNLF.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALNLF.PA Per share dataALNLF.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.02 0.04 0.06 0.08 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALNLF!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEOLIFE

EPA:ALNLF (3/7/2025, 7:00:00 PM)

0.076

+0.01 (+13.77%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap7.32M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.64
P/FCF N/A
P/OCF N/A
P/B 1.7
P/tB 7.45
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.12
BVpS0.04
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.77%
ROE -3.39%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.86%
FCFM N/A
ROA(3y)-18.07%
ROA(5y)-15.86%
ROE(3y)-31.58%
ROE(5y)-31.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-24.38%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.38
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 0.86
Altman-Z 2.52
F-ScoreN/A
WACC6.88%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)96.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-45.22%
Revenue growth 3Y17.93%
Revenue growth 5Y14.19%
Sales Q2Q%-18.81%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y90.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A